LifeVantage Co. (NASDAQ:LFVN) Short Interest Down 8.3% in June

LifeVantage Co. (NASDAQ:LFVN) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 77,100 shares, a decrease of 8.3% from the June 15th total of 84,100 shares. Based on an average trading volume of 43,200 shares, the days-to-cover ratio is presently 1.8 days. Approximately 0.8% of the company’s stock are sold short.

Hedge Funds Weigh In On LifeVantage

Hedge funds and other institutional investors have recently modified their holdings of the stock. Hillsdale Investment Management Inc. purchased a new position in shares of LifeVantage in the 1st quarter valued at approximately $76,000. Ritholtz Wealth Management raised its position in shares of LifeVantage by 23.5% in the 4th quarter. Ritholtz Wealth Management now owns 25,027 shares of the company’s stock valued at $150,000 after purchasing an additional 4,756 shares during the last quarter. Empowered Funds LLC raised its position in shares of LifeVantage by 8.1% in the 1st quarter. Empowered Funds LLC now owns 76,203 shares of the company’s stock valued at $461,000 after purchasing an additional 5,742 shares during the last quarter. Acadian Asset Management LLC raised its position in shares of LifeVantage by 2.8% in the 1st quarter. Acadian Asset Management LLC now owns 228,088 shares of the company’s stock valued at $1,378,000 after purchasing an additional 6,121 shares during the last quarter. Finally, Vanguard Group Inc. raised its position in shares of LifeVantage by 2.8% in the 1st quarter. Vanguard Group Inc. now owns 475,021 shares of the company’s stock valued at $2,874,000 after purchasing an additional 12,809 shares during the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

LifeVantage Price Performance

Shares of LFVN stock traded down $0.04 during mid-day trading on Tuesday, hitting $6.22. 55,754 shares of the stock traded hands, compared to its average volume of 39,584. The stock has a market cap of $78.99 million, a P/E ratio of 22.57 and a beta of 0.81. The stock’s fifty day moving average is $6.89 and its two-hundred day moving average is $6.50. LifeVantage has a 52-week low of $4.20 and a 52-week high of $8.69.

LifeVantage (NASDAQ:LFVN) last released its quarterly earnings results on Thursday, May 2nd. The company reported $0.21 EPS for the quarter. The business had revenue of $48.25 million during the quarter. LifeVantage had a net margin of 1.75% and a return on equity of 27.02%.

LifeVantage Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 14th. Shareholders of record on Friday, May 31st were given a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 2.57%. This is a positive change from LifeVantage’s previous quarterly dividend of $0.04. The ex-dividend date of this dividend was Friday, May 31st. LifeVantage’s dividend payout ratio is presently 57.14%.

LifeVantage Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.